Introduction. Testicular microdissection sperm extraction (MD-TESE) combined with intracytoplasmic sperm injection (ICSI) has made biological fatherhood possible for many men with the most severe form of male infertility, non-obstructive azoospermia. MD-TESE was introduced in Turku in 2008, and by 2015, 100 Finnish men with non-obstructive azoospermia have been operated on. Material and methods. The average age of the men was 33 years at the time of surgery. Forty-eight had a needle biopsy previously and 56% had a testicular size <15 mL. The most common diagnoses were idiopathic (n = 65), Klinefelter syndrome (n = 15), operated cryptorchidism or torsion (n = 10), and Y chromosome microdeletion (n = 7). The pregnancy outcomes were followed. Results. The sperm recovery rate (SRR) overall was 42%: 31% for idiopathic non-obstructive azoospermia, 40% for Klinefelter syndrome, 57% for Y chromosome microdeletion AZFc, 90% for previous testicular surgery (mostly for cryptorchidism; n = 10) and 67% for previous cytotoxic treatment (n = 3). SRR with histopathologic diagnosis Sertoli-cellonly was 29%, and 44% for spermatogenic arrest. Age did not affect the outcome of the surgery. Small testicular size seemed to predict a higher SRR. A previous needle biopsy did not predict a lower SRR. Surgical complications were rare. Of couples, 32 had at least one ICSI attempt, and 22 at least one live birth, giving a cumulative live birth rate of 69%. No major pregnancy complications occurred. Conclusions. Our SRR is comparable with international results, and the cumulative live birth rate similar to other ICSI indications in Finland. Physicians and specialists need to be made aware of new treatment options to enable biological fatherhood for men with nonobstructive azoospermia.
Introduction
Azoospermia is defined by complete absence of spermatozoa in at least two repeated semen analyses. Azoospermia is thought to be present in approximately 1% of adult men (1) , and in approximately 10-15% infertile males
Key message
Testicular microdissection combined with intracytoplasmic sperm injection is an effective treatment option for severe male infertility and should be actively offered to men with non-obstructive azoospermia wishing to father biological children.
ª 2017 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 97 (2018) 53-58 (2) . In obstructive azoospermia (OA), spermatozoa are not present in semen in spite of normal spermatogenesis in testis, due to a mechanical blockage along the genital tract caused, for example, by prior vasectomy, trauma, anomaly or infection. In contrast, in non-obstructive azoospermia (NOA), spermatogenetic function of the testis is impaired. This is typically associated with significant hormonal abnormalities, characteristically elevated serum levels of follicle stimulating hormone (FSH); serum testosterone levels, however, may be low or normal. The etiology of NOA includes genetic abnormalities, postinfectious conditions, trauma, congenital abnormalities, cytotoxic medications, radiation and malignant disease, but idiopathic NOA is also common (3) .
The treatment of severe male infertility was made possible by the invention of intracytoplasmic sperm injection (ICSI) (4, 5) , and men with OA have been able to father children since the early 1990s with the use of spermatozoa found by testicular or epididymal rough needle biopsy (5) . These needle aspiration techniques are rarely successful in recovering spermatozoa in men with NOA. However, spermatogenesis may be present in small areas in the testis, and the principle of testicular microdissection (MD-TESE), described by Schlegel (6) , is to identify these areas by an operating microscope and aim the biopsies at these specific areas. Sperm recovery rates (SRR) vary, being around 40-50% in well-defined NOA populations (7, 8) . SRR varies according to the histopathological diagnosis as well as the cause of NOA. Very reassuring reports of the health of the children born after TESE-ICSI have been published (9) . Some data are available on cumulative live birth rates after the diagnosis of NOA. Vloeberghs et al. reported in 2017 that only 13% of the men with treated NOA, fathered biological children by TESE-ICSI (10) .
SRR rates in men with NOA in MD-TESE, conventional testicular sperm extraction and testicular sperm aspiration have been compared in several studies, as discussed in a meta-analysis by Bernie et al. (11) in 2015. MD-TESE leads to higher SRR compared with conventional testicular sperm extraction, which is twice as likely to find sperm compared with testicular sperm aspiration. MD-TESE has lower complication rates compared with conventional TESE (8) .
In 2007, the Finnish act on assisted fertility treatments became effective, banning anonymous gamete donation [Assisted Reproduction Technology (ART) Act, 1237/ 2006]. The number of men willing to donate sperm initially plummeted, which brought about the motivation to learn and introduce the MD-TESE method to enable Finnish men with NOA to father children by ICSI. In a small country with a population of 5.5 million people, there are 17 IVF clinics, 11 of which are private. Successful cryopreservation of the recovered spermatozoa enables Finnish clinics to centralize the MD-TESE treatment of men with NOA to Turku and to carry out the ICSI treatment without simultaneous coordination. The aim of this paper is to retrospectively analyze and discuss the experience on the first 100 men operated on in Turku University Hospital in 2008-2015.
Material and methods
We analyzed the first consecutive 100 men operated on from 2008 to 2015. NOA was diagnosed by repeated semen analyses (12) , endocrine and genetic analysis -Y chromosome microdeletions a-c, karyotype, serum concentrations of follicle stimulating hormone (FSH), luteinizing hormone, testosterone, prolactin (PRL), thyroid stimulating hormone -with a physical evaluation including testicular ultrasonography. Of the 100 men, 50% had had a previous needle aspiration biopsy, but none had gone through previous MD-TESE. The needle biopsies were performed in different clinics using different methods, and only men with previous negative biopsies were operated on and included in this study. The histopathological diagnosis in nearly all previously biopsied men was Sertoli-cell-only syndrome (n = 41), with only a few spermatogenic arrest diagnoses (n = 9). At the time of the operation, the average age was 33.4 years (range 21-47). Testicular size was <15 mL in 56% of the men, measured by orchidometry at surgery. The testicular size correlated with the diagnosis and histopathology; all the men with Klinefelter syndrome (KS) had a testicular size <5 mL, whereas all the men with spermatogenic arrest had a normal testicular size (>15 mL). Mean testicular size was 13 mL and median testicular size was 12 mL.
Klinefelter syndrome was diagnosed in 15% and Ydeletion AFZc in 7%. Three men had been treated with cytotoxic medication or radiation, and 10% had previous cryptorchidism or torsion as the likely cause of NOA. In 65% of the men, the NOA was considered idiopathic, with no identifiable cause.
The men with low testosterone were treated with aromatase inhibitor (n = 26), clomifene citrate (n = 5), tamoxifen (n = 11) or human chorionic gonadotropin (n = 6) for four to six months prior to the operation in order to reach normal serum testosterone levels. All men with KS were treated with an aromatase inhibitor if they could tolerate the treatment. A total of 48% of the men operated on received medical treatment prior to the procedure. The average pretreatment testosterone level was 7.4 nmol/L and post-treatment level 22.1 nmol/L. Unfortunately, complete data were available only in 35 men treated medically because in some cases the treatment had been initiated at another hospital.
The MD-TESE procedures were carried out under general anesthesia. The skin was incised in the scrotal midline, and the tunica albuguinea was vertically opened in most cases. An operating microscope was used to target the biopsies at potentially sperm-producing tubules, opaque and larger in diameter. Biopsies were immediately taken to the IVF laboratory for examination by higher magnification (400 9 ). Until a sufficient amount of sperm for the purposes of ICSI was recovered, up to 20 biopsies were taken and the procedure was then repeated on the other side. The procedure was discontinued when the entire testis had been mapped for suitable tubuli. MD-TESE was performed independently of interventions on the female partner, if any -a few patients were young men with KS hoping to preserve their fertility before being put on testosterone treatment. The extracted testicular tissue was mechanically dispersed and the cell suspension was thoroughly examined by a single, experienced embryologist using a microscope. If no sperm was found, a collagenase digestion was performed and the tissue was re-examined. A biopsy was sent for histopathology in most cases, even when a previous histopathological diagnosis was available. MD-TESE was combined with cryopreservation of testicular tissue whenever sperm retrieval was achieved.
Thirty-two couples have gone through at least one cycle of TESE-ICSI. The straws of cryopreserved testicular tissue were transferred to 10 different fertility clinics in Finland for the appropriate ICSI treatment. Different stimulation protocols were used. Several other factors affecting the ICSI outcome, for example age, weight and other health issues of the female partner, varied significantly.
Four couples have discontinued their fertility treatment for unknown reasons and three couples initially intending to have ICSI treatment have not started with their first treatment cycle. Seven men in whom sperm was recovered and frozen have not to date contacted any clinic to receive further fertility treatment. Five young men with KS went through the procedure initially to preserve their fertility, the other two have been lost to follow up.
Statistical analyses
SAS for Windows version 9.4 (SAS Institute, Cary, NC, USA) was used for data analysis. A significance level of 0.05 was considered statistically significant. Differences in sperm recovery in relation to categorical variables (medical treatment, previous unsuccessful needle biopsy and small testicular size) were analyzed using a logistic regression analysis. Age in relation to surgical success was analyzed by an independent sample t-test. The serum hormone concentrations in relation to sperm recovery were compared by Mann-Whitney U-test. Due to the small numbers, no significance was shown; however, in some groups, a tendency was observed.
Ethical approval
Since no intervention was performed, this research article is not considered a trial which would require ethical approval or an official registration by Finnish law (http:// www.finlex.fi/fi/laki/ajantasa/1999/19990488).
Results
Sperm was retrieved and frozen from 42% of the men with NOA by MD-TESE. There was clear variation between different patient groups: the SRR for idiopathic NOA was 31% (n = 65), KS 40% (n = 15), Y chromosome microdeletion AFZc 57% (n = 7), previous cytotoxic treatment 67% (n = 3) and previous testicular surgery 90% (cryptorchidism or torsion; n = 10). The MD-TESE procedure tended to be more successful in men with small testes (<15 mL) than in men with normal size testes (46 vs. 36%; p = 0.339). Serum FSH displayed a wide range of variation, but the level was not predictive for sperm recovery (21.5 vs. 24.2 IU/L; p = 0.488). The age of the patient at the time of the surgery did not predict sperm recovery (32.9 vs. 33.7 years; p = 0.496). A previous unsuccessful needle biopsy did not predict a lower SRR (45.8 vs. 38.5%; p = 0.456). In men with a previous histopathological diagnosis of Sertoli-cell-only, SRR was 29%, while a previous biopsy with spermatogenic arrest diagnosis gave an SRR of 44%.
There was no difference in the SRR between the medically treated and untreated groups (42.5 and 41.5%, respectively; p = 0.782).
No clear learning curve was apparent in our data, as the SRR of the first 33 men was 39%, the next 34 was 39% and the last 33 was 48%.
Thirty-two couples had gone through at least one attempt at TESE-ICSI. In 22 families there was at least one live birth, giving a cumulative live birth rate of 69%. There were two sets of twins. Four couples with no live birth had gone through only one ICSI cycle. Some continue to be treated. In three of the couples with failed ICSI, the female partner was over 40 years of age. Our follow-up data may not be entirely complete since the cryopreserved tissue has been shipped to other clinics, where TESE-ICSI will be carried out at a later stage.
In our data of 100 MD-TESE patients, we had two cases of epididymitis and four other infections treated with oral antibiotics, two hematomas that were followed without intervention, and one abscess requiring surgical treatment, giving an overall complication rate of 9%. We did not systematically control serum testosterone levels after the surgery, except for the men who had been on medical treatment prior to the surgery. Symptomatic men with low testosterone were started on testosterone treatment.
Discussion
SRR varies according to the diagnosis and histopathology (13) , as shown also in our data (Table 1) . No group had an SRR low enough to refrain from attempting sperm recovery, and the group with the most modest SRR (29%) had in fact a very reassuring pregnancy rate (73%, Table 2 ) in ICSI (idiopathic azoospermia with Sertolicell-only histopathology). In our study population, men with a previous negative needle biopsy had the same SRR as those with no previous biopsy, and only 50% had gone through needle biopsy. We used the Bard Monopty 14G biopsy gun for multiple, bilateral biopsies, but the biopsy methods used in other hospitals were not asked about. NOA can be diagnosed with high sensitivity and specificity without testicular biopsy in the majority of cases (14) . In our opinion, MD-TESE can often be offered as the first line procedure for men with a clear NOA diagnosis.
In the men studied, there was no difference in sperm retrieval results related to patient age. Age does not seem to affect adversely the sperm retrieval in general MD-TESE population (15) . However, men with KS may form an exception and may have a worsening SRR with advancing age. The current opinion does not support MD-TESE and cryopreservation of sperm in adolescent men with KS, since the SRR remains good in young adulthood (15, 16) .
There are differences in ICSI outcome in the different subgroups of men with NOA (13) , and these differences are also seen in our study population (Table 2 ), but our patient number is insufficient for detailed statistical analysis. Sperm from men with Y-deletion AZFc, for instance, are well documented to give good ICSI results in larger trials (17) . More data are needed on ICSI outcome to improve patient counseling prior to MD-TESE for NOA men with different underlying diagnoses.
The role of medical treatment prior to MD-TESE is not conclusively documented but there is a consensus on attempting to optimize serum testosterone level prior to MD-TESE (18) . Treatment options include aromatase inhibitors, human chorionic gonadotropin and antiestrogens, but few data are available on the differences between these medical treatment options in terms of the effect on hormone levels or adverse effects (19) . Our data do not provide any further information on whether medical treatment is useful for some patients waiting to be operated on. A major problem with our data was that pre-and post-treatment testosterone levels were not consistently reported to us. Different laboratory methods and threshold levels may also have impacted our results. We have not changed our practice to medically treat only the men with abnormal or borderline low serum testosterone levels (<13 nmol/L).
The outcome of ICSI using frozen-thawed testicular sperm does not seem to suffer from the previously reported fact that there is an increased risk of not finding sufficient sperm after thawing (20) . However, no such event was reported by the participating clinics concerning our population. To ensure good results, all fertility laboratories performing ICSI using MD-TESE sperm need to be appropriately educated on the process and laboratory practices for using MD-TESE recovered sperm for ICSI. Recent studies regarding the cumulative delivery rate after MD-TESE have raised concern, showing only a 13% cumulative live birth rate in men with NOA undergoing TESE, largely due to drop-out (10) . In our limited data, where nearly half of the couples had only had one ICSI attempt, 69% had at least one delivery (giving a cumulative live birth rate of 22%). Comparing ICSI results between MD-TESE patients and the general ICSI population is difficult due to major differences. Fertility preservation patients form a very unique patient subgroup (21) , which should be excluded from the analysis. However, there is a substantial patient drop-out of azoospermic men, perhaps due to psychological aspects (22) . This is an issue that should be considered in more detail when counseling azoospermic men. The age of the female partner is an important factor affecting the outcome of assisted reproductive techniques. Couples with a female partner approaching 40 years of age may need to consider opting for donor sperm treatment to achieve the best results (23) .
Y chromosome microdeletion is consistently passed on to male offspring, and couples need to be given genetic counseling prior to ICSI treatment. The large number of healthy children born to fathers with KS (24) is beginning to indicate conclusively that no preimplantation diagnosis or invasive fetal genetic testing is needed in pregnancies conceived with sperm from men with KS. All of our men with KS and Y chromosome microdeletion received preoperative genetic counseling in order to inform the treated couples on these important issues.
No major pregnancy complications occurred in our limited data, and the children have been born healthy. The twinning rate was 9%, compared with a 5% rate in the Finnish general ART population in 2014-2015, most likely due to a larger proportion of double embryo transfers in our study population. Now that the pregnancy rates of MD-TESE-ICSI treatments are proving similar to the general IVF/ICSI rates, this important risk factor should be avoided by primarily choosing single embryo transfer.
MD-TESE is known to somewhat decrease serum testosterone concentration, but this effect has been shown to be reversible in most individuals (25) . As far as we know, none of the men in our study group with a previously normal serum testosterone level required testosterone therapy following MD-TESE. The postoperative testosterone levels were controlled in the men with initially low testosterone level and in the men presenting with symptoms consistent with low testosterone. Symptomatic men with low testosterone were started on testosterone treatment. The use of antibiotic prophylaxis became routine after the first 45 operations. Since this change in practice we have only treated one postoperative infection. The patients were advised to contact our clinic if there were any signs of postoperative complications. However, it is possible that some locally treated minor complications are missing from our data.
Predicting SRR prognosis in men with NOA remains impossible. Our data are consistent with previous data showing that age, previous needle biopsy, serum FSH or other hormone levels do not reliably predict MD-TESE outcome. A method of "mapping" the testes by multiple fine needle biopsies has been described to detect the presence of sperm to tailor the method of sperm retrieval with a low complication rate (26) . New prediction models based on multiple variables, for instance age, serum hormone levels and etiology of the NOA, may prove useful in distinguishing between men with good and less favorable prognoses, but the results are still preliminary (27) . This may assist the clinician and the patient in decision-making, but more research is needed to find reliable methods to predict MD-TESE outcome.
Conclusions
The use of MD-TESE to optimize SRR in NOA has been well documented in the literature. Our results are comparable with international data from large centers. In our study population, men with a previous negative needle biopsy had the same SRR as those with no previous biopsy. Since NOA can be diagnosed with high sensitivity and specificity without testicular biopsy, MD-TESE can often be offered as the first line procedure. Physicians and specialists counseling men with NOA need to be made aware of these patients' chance of fathering biological children through TESE-ICSI.
